Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak

Endocrinology

Volumn 147, Issue 10, 2006, Pages 4960-4967

  Castilla, Carolina ^a   Congregado, Belén ^a   Chinchón, David ^a   Torrubia, Francisco J ^a   Japón, Miguel A ^a   Sáez, Carmen ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE INHIBITOR; PROTEIN BAK; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER SURVIVAL; CELL STRAIN LNCAP; CONTROLLED STUDY; GLEASON SCORE; HORMONE RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; IN VIVO STUDY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOTTING, WESTERN; CAMPTOTHECIN; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; PHENOTYPE; PROSTATIC NEOPLASMS;

EID: 33748754286     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-0502     Document Type: Article

References (46)

1. Santen RJ 1992 Endocrine treatment of prostate cancer. J Clin Endocrinol Metab 75:685-689
2. Buttyan R, Zhang X, Dorai T, Olsson CA 1997 Anti-apoptosis genes and the development of hormone-resistant prostate cancer. In: Naz RK, ed. Prostate: basic and clinical aspects. Boca Raton, FL: CRC Press; 201-221
3. Colombel M, Symmans F, Gil S, O'Toole KM, Chopin D, Benson M, Olsson CA, Korsmeyer S, Buttyan R 1993 Detection of the apoptosis suppressing oncoprotein bcl-2 in hormone refractory human prostate cancers. Am J Pathol 143:390-400
4. McDonell TJ, Troncoso P, Brisbay SM, Logothesis C, Chang LWK, Hsieh JT, Tu SM, Campbell ML 1992 Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944
5. Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC 1996 Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 148:1567-1576
6. Johnson MI, Robinson MC, Marsh C, Robson CN, Neal DE, Hamdy FC 1998 Expression of Bcl-2, Bax, and p53 in high-grade prostatic intraepithelial neoplasia and localized prostate cancer: relationship with apoptosis and proliferation. Prostate 37:223-229
7. Liu QY, Stein CA 1997 Taxol and estramustine-induced modulation of human prostate cancer cell apoptosis via alteration in bcl-xL and bak expression. Clin Cancer Res 3:2039-2046
8. L underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells. Cancer Res 61:1699-1706
9. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredsen D, Reed JC 1998 Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Acad Sci USA 95:4997-5002
10. Minn AJ, Kettlun CS, Liang H, Kelekar A, Van der Heiden MG, Chang BS, Fesik SW, Fill M, Thompson CB 1999 Bcl-xL regulates apoptosis by heterodimerization-dependent and independent mechanisms. EMBO J 18:632-643
11. Wei MC, Zong WX, Cheng EHY, Lindsten T, Panaoutsakopoulou V, Ross AJ, Roth KA, MacGregor GR, Thompson S, Korsmeyer SJ 2001 Proapoptotic Bax and Bak: a requisite gateway to mitochondrial dysfunction and death. Science 292:727-730
12. Marcelli M, Marani M, Li X, Sturgis L, Haidacher SJ, Trial JA, Mannucci R, Nicoletti I, Denner L 2000 Heterogeneous apoptotic responses of prostate cancer cell lines identify an association between sensitivity to staurosporine-induced apoptosis, expression of Bcl-2 family members, and caspase activation. Prostate 42:260-273
13. Huang DC, Strasser A 2000 BH3-only proteins - essential initiators of apoptotic cell death. Cell 103:839-842
14. Adams JM 2003 Ways of dying: multiple pathways to apoptosis. Genes Dev 17:2481-2495
15. Wei MC, Lindsten T, Mootha VK, Weiler S, Goss A, Ashiya M, Thompson CB, Korsmeyer SJ 2000 tBid, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14:2060-2071
16. Roucou X, Montessuit S, Antonsson B, Martinou JC 2002 Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem J 368:915-921
17. L, but not Bcl-2, until displaced by BH3-only proteins. Genes Dev 19:1294-1305
18. Shiau CW, Huang JW, Wang DS, Weng JR, Yang CC, Lin CH, Li C, Chen CS 2006 α-Tocopheryl succinate induces apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 function. J Biol Chem 281:11819-11825
19. Hsu YT, Youle RJ 1997 Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272:13829-13834
20. Nechushtan A, Smith CL, Hsu YT, Youle RJ 1999 Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J 18:2330-2341
21. Antonsson B, Montessuit S, Sanchez B, Martinou JC 2001 Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J Biol Chem 276:11615-11623
22. Mikhailov V, Mikhailova M, Pulkrabek DJ, Dong Z, Venkatalacham MA, Saikumar P 2001 Bcl-2 prevents Bax oligomerization in the mitochondrial outer membrane. J Biol Chem 276:18361-18374
23. Dejean LM, Martinez-Caballero S, Guo L, Hughes C, Teijido O, Ducret T, Ichas F, Korsmeyer SJ, Antonsson B, Jonas EA, Kinnally KW 2005 Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol Biol Cell 16:2424-2432
24. Zi X, Simoneau AR 2005 Flavokawain A, a novel chalcone from kava extract, induces apoptosis in bladder cancer cells by involvement of Bax protein-dependent and mitochondria-dependent apoptotic pathway and suppresses tumor growth in mice. Cancer Res 65:3479-3486
25. Upreti M, Lyle CS, Skaug B, Du L, Chambers TC 2006 Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members. J Biol Chem 281:15941-15950
26. Cuddeback SM, Yamaguchi H, Komatsu K, Miyushita T, Yamada M, Wu C, Singh S, Wang HB 2001 Molecular cloning and characterization of Bif-1. J Biol Chem 276:20559-20565
27. Nomura M, Shimizu S, Sugiyama T 2003 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 278:2058-2065
28. Gupta S, Knowlton AA 2002 Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 106:2727-2733
29. Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S 2003 Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 5:320-329
30. Willis SN, Adams JM 2005 Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol 17:617-625
31. Mills SE, Fowler JE 1986 Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 53:346-349
32. Eisenberger MA, Walsh PC 1999 Early androgen deprivation for prostate cancer. N Engl J Med 341:1837-1838
33. Adams JM, Cory S 1998 The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326
34. Gross A, McDonnell JM, Korsmeyer SJ 1999 BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911
35. Kojima H, Endo K, Moriyama H, Tanaka Y, Alnemri ES, Slapak CA, Teicher B, Kufe D, Datta R 1998 Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem 237:16647-16650
36. Roy G, Horton JK, Roy R, Denning T, Mitra S, Boldogh I 2000 Acquired alkylating drug resistance of a human ovarian carcinoma cell line is unaffected by altered levels of pro- and anti-apoptotic proteins. Oncogene 19:141-150
37. Krajewska M, Moss SK, Krajewski S, Song K, Holt PR, Reed JC 1996 Elevated expression of Bcl-x and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 56:2422-2427
38. Foreman KE, Wrone-Smith LH, Boise CB, Thompson CB, Polverini PJ, Simonian PL, Nuñez G, Nickoloff BJ 1996 Kaposi's sarcoma tumor cells preferentially express. Bcl-xL. Am J Pathol 149:795-803
39. Tu Y, Renner F, Xu A, Fleishman A, Taylor J, Weisz J, Vescio R, Rettig M, Berenson J, Krajewski S, Reed JC, Lichtenstein A 1998 Bcl-x expression in multiple myeloma: possible indicator of chemoresistance. Cancer Res 58:256-262
40. Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H 2001 Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 34:55-61
41. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B, Martinou JC 1999 Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Biol Chem 144:891-901
42. Degterev A, Lugovskoy A, Cardone M, Mulley B, Wagner G, Mitchison T, Yuan J 2001 Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol 3:173-182
43. Chipuk JE, Bouchier-Hayes L, Kuwana T, Newmeyer DD, Green DR 2005 PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science 309:1732-1735
44. Ming L, Wang P, Bank A, Yu J, Zhang L 2006 PUMA dissociates Bax and BCL-XL to induce apoptosis in colon cancer cells. J Biol Chem 281:16034-16042
45. Hsu YT, Youle RJ 1998 Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J Biol Chem 273:10777-10783
46. Wang XZ, Beebe JR, Pwiti L, Bielawska A, Smyth MJ 1999 Aberrant sphingolipid signalling is involved in the resistance of prostate cancer cell lines to chemotherapy. Cancer Res 59:5842-5848